Lyfebulb and Celgene recently announced the finalists for the 2019 "Addressing Unmet Needs in MS: An Innovation Challenge". Loro, along with nine other finalists, have been selected to compete at the Innovation Challenge Summit on June 13 for a $25,000 monetary grant to further develop their innovations. All the finalists selected are helping to address an unmet need in Multiple Sclerosis (MS) patients and are helping members of the MS community live more comfortable lives.
The summit will bring together patient entrepreneurs, judges, and members of the Celgene and Lyfebulb teams for an engaging and interactive competition. "Ultimately, we hope to foster discussion about ways to advance innovation in the space and look forward to awarding this grant that will help support people with MS and their families." said Terrie Curran, President, Celgene Inflammation and Immunology. This is a very exciting opportunity for Loro to share our passion for bringing mobility and independence to those with physical challenges.
Read the full article on the Innovation Challenge here: https://www.bloomberg.com/press-releases/2019-05-10/lyfebulb-and-celgene-announce-finalists-for-2019-addressing-unmet-needs-in-ms-an-innovation-challenge
34 views0 comments